摘要
本研究回顾性分析南京鼓楼医院收治的37例行新辅助雄激素剥夺治疗(ADT)患者的病例资料,分析治疗前后患者68Ga-PSMAPET/CT检查的变化,结果显示经6个月新辅助ADT后患者68Ga-PSMAPET/CT检查上前列腺癌原发灶的可见度降低。
This study reviewed 37 patients who received neoadjuvant ADT in our center and analyzed the change of 68Ga-PSMA PET/CT before and after treatment.This study found that neoadjuvant ADT significantly reduced the tumor visibility on 68Ga-PSMA PET/CT.
作者
陈梦霞
尹皓立
杨阳
臧士明
王峰
郭宏骞
Chen Mengxia;Yin Haoli;Yang Yang;Zang Shiming;Wang Feng;Guo Hongqian(Department of Urology,Affiliated Drum Tower Hospital,Medical School of Nanjing University,Institute of Urology,Nanjing University,Nanjing 210008,China;Department of Nuclear Medicine,Nanjing First Hospital,Nanjing Medical University,Nanjing 210006,China)
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
2023年第8期630-631,共2页
Chinese Journal of Urology
